The EMA reverses its previous decision and grants marketing authorization to the world’s first drug specifically approved for treating the syndrome.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/trofinetide-approved-rett-syndrome-after-reexamination-2026a1000lul?src=rss
Author :
Publish date : 2026-06-26 15:21:00
Copyright for syndicated content belongs to the linked Source.